Sergio Araujo1,2, Larissa Oliveira Freitas1, Luiz Ricardo Goulart1,2,3,4, Isabela Maria Bernardes Goulart1,2. 1. National Reference Center for Sanitary Dermatology and Leprosy, Clinics Hospital. 2. Postgraduate Program in Health Sciences, School of Medicine. 3. Institute of Biochemistry and Genetics, Federal University of Uberlandia, Minas Gerais, Brazil. 4. Department of Medical Microbiology and Immunology, University of California, Davis.
Abstract
BACKGROUND: Leprosy persists as a public health problem. The chain of transmission and mechanism of infection are not completely understood. In the current study, we investigated the route of infection and of disease onset, from airway exposure, colonization, and bloodstream dissemination. METHODS: Mycobacterium leprae DNA was detected through quantitative polymerase chain reaction in nasal vestibule, nasal turbinate mucosa, and peripheral blood samples, along with anti-phenolic glycolipid I serology and skin tests from the same individual, from 113 leprosy patients and 104 household contacts of patients (HHCs). Bivariate statistics and multiple correspondence analysis were employed. RESULTS: The rates of DNA positivity among patients were 66.4% (75 of 113) for nasal swab samples, 71.7% (81 of 113) for nasal turbinate biopsy samples, 19.5% (22 of 113) for blood samples, with seropositivity of 62.8% (71 of 113 samples) and with increasing incidences toward the multibacillary pole of the clinical spectrum. Positivity among HHCs were as follows: 49% (51 of 104) for nasal swab samples, 53.8% (56 of 104) for nasal biopsy samples, 6.7% (7 of 104) for blood samples, and 18.3% (19 of 104 samples) for anti-phenolic glycolipid I serology. During the follow-up of 5-7 years, out of 104 HHCs, 7 developed leprosy (6.7%). Risk for the disease outcome was estimated by comparing results in HHCs who develop leprosy with those not affected. Neither nasal passage nor mucosa positivity was determinant of later disease onset; however, blood presence increased the risk for disease development (relative risk/positive likelihood ratio, 5.54; 95% confidence interval, 1.30-23.62), as did seropositivity (positive likelihood ratio, 3.69 [1.67-8.16]; relative risk, 5.97 [1.45-24.5]). CONCLUSIONS: Our findings strongly suggest that the aerosol route of infection and transmission is predominant and that HHCs contribute to the infection risk to themselves and probably to others.
BACKGROUND:Leprosy persists as a public health problem. The chain of transmission and mechanism of infection are not completely understood. In the current study, we investigated the route of infection and of disease onset, from airway exposure, colonization, and bloodstream dissemination. METHODS:Mycobacterium leprae DNA was detected through quantitative polymerase chain reaction in nasal vestibule, nasal turbinate mucosa, and peripheral blood samples, along with anti-phenolic glycolipid I serology and skin tests from the same individual, from 113 leprosypatients and 104 household contacts of patients (HHCs). Bivariate statistics and multiple correspondence analysis were employed. RESULTS: The rates of DNA positivity among patients were 66.4% (75 of 113) for nasal swab samples, 71.7% (81 of 113) for nasal turbinate biopsy samples, 19.5% (22 of 113) for blood samples, with seropositivity of 62.8% (71 of 113 samples) and with increasing incidences toward the multibacillary pole of the clinical spectrum. Positivity among HHCs were as follows: 49% (51 of 104) for nasal swab samples, 53.8% (56 of 104) for nasal biopsy samples, 6.7% (7 of 104) for blood samples, and 18.3% (19 of 104 samples) for anti-phenolic glycolipid I serology. During the follow-up of 5-7 years, out of 104 HHCs, 7 developed leprosy (6.7%). Risk for the disease outcome was estimated by comparing results in HHCs who develop leprosy with those not affected. Neither nasal passage nor mucosa positivity was determinant of later disease onset; however, blood presence increased the risk for disease development (relative risk/positive likelihood ratio, 5.54; 95% confidence interval, 1.30-23.62), as did seropositivity (positive likelihood ratio, 3.69 [1.67-8.16]; relative risk, 5.97 [1.45-24.5]). CONCLUSIONS: Our findings strongly suggest that the aerosol route of infection and transmission is predominant and that HHCs contribute to the infection risk to themselves and probably to others.
Authors: Lívia Érika Carlos Marques; Cristiane Cunha Frota; Josiane da Silva Quetz; Alexandre Havt Bindá; Rosa Maria Salane Mota; Maria Araci de Andrade Pontes; Heitor de Sá Gonçalves; Carl Kendall; Ligia Regina Franco Sansigolo Kerr Journal: Pathog Glob Health Date: 2017-12-26 Impact factor: 2.894
Authors: Carlos Franco-Paredes; Luis A Marcos; Andrés F Henao-Martínez; Alfonso J Rodríguez-Morales; Wilmer E Villamil-Gómez; Eduardo Gotuzzo; Alexandro Bonifaz Journal: Clin Microbiol Rev Date: 2018-11-14 Impact factor: 26.132
Authors: Edilamar Silva de Alecrin; Ana Laura Grossi de Oliveira; Nathália Sernizon Guimarães; Sandra Lyon; Maria Auxiliadora Parreiras Martins; Manoel Otávio da Costa Rocha Journal: Rev Inst Med Trop Sao Paulo Date: 2022-09-30 Impact factor: 2.169
Authors: Moises B da Silva; Juliana M Portela; Wei Li; Mary Jackson; Mercedes Gonzalez-Juarrero; Andrea Sánchez Hidalgo; John T Belisle; Raquel C Bouth; Angélica R Gobbo; Josafá G Barreto; Antonio H H Minervino; Stewart T Cole; Charlotte Avanzi; Philippe Busso; Marco A C Frade; Annemieke Geluk; Claudio G Salgado; John S Spencer Journal: PLoS Negl Trop Dis Date: 2018-06-28
Authors: Amanda N B Fontes; Luana N G C Lima; Rosa M S Mota; Rosa L F Almeida; Maria A Pontes; Heitor de S Gonçalves; Cristiane C Frota; Varalakshmi D Vissa; Patrick J Brennan; Ricardo J P S Guimaraes; Carl Kendall; Ligia R F S Kerr; Philip N Suffys Journal: PLoS Negl Trop Dis Date: 2017-12-15